pharmacogenomics

Welcome to the MedTek21 News Center

July 25, 2018

MedTek21 v4.0 Expands Advanced Genomic Reporting, Alerts, and Real-time Connectivity to More Health Information Systems

July 25, 2018 – West Chester, PA – MedTek21 today announced the general availability of Version 4.0 of the MedTek21 personalized medication management software platform.  The enhancements in MedTek21 v.4.0 will empower millions of patients, pharmacists, and care providers to […]
July 23, 2018

MedTek21 on the ShiftShapers Podcast

Joe Spinelli, Chief Commercial Officer of MedTek21, joined the ShiftShapers Podcast for a conversation on pharmacogenomics and its impact on lowering cost and improving care.  A link to this episode can be found below: Ep #224: Science vs. Drugs: Lower Cost and Better User […]
June 5, 2018
FamilyWize Logo

MedTek21 Partners with FamilyWize

MedTek21 and FamilyWize announced today a partnership that will give the public greater access to personalized medicine, helping patients better understand how their unique genetic profiles can influence how they metabolize certain medications. FamilyWize and MedTek21 can help patients by offering access […]
May 1, 2018
Leading-AGE_PNG

MedTek21 Team to Present at LeadingAge Michigan

Team members from MedTek21, a leading provider of personalized medication management software, will be presenting at the 50th annual LeadingAge Michigan Conference and Solutions Expo. The conference will be held from May 20th-23rd, 2018. The session entitled “Personalized Medicine for […]
December 15, 2016
unnamed-e1481697342579

MedTek21 Partners with Translational Software

MedTek21 and Translational Software (TSI) announced the TSIs PGx knowledge platform and Application Programming Interface (API) will enable PGx-based prescribing seamlessly within MedTek21’s population health and medication risk management platform. This partnership will help to guide treatment decisions and support […]
December 10, 2016
clinical_trial_recruitment

JAMA: Getting Pharmacogenomics Into the Clinic

What if there were a way to know if a depressed patient would respond to an antidepressant—before it was prescribed? Or to predict a bleeding event from an antiplatelet therapy? In recent years, advances in genetic testing have made such […]